Skip to main content

Aclaris Therapeutics, Inc.

ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001557746

No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.

13F holders, Q4 2025

Institutional positions in Aclaris Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
122
+19 vs. Q3 2025
Shares held
83.7M
−1.94M (−2.3%) vs. Q3 2025
Total value
$252.1M
+$89.3M (+54.8%) vs. Q3 2025
New holders
25
34 more added
Sold out
6
40 more reduced

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ACRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 122 institutions
Q1 2021: 97 institutionsQ2 2021: 128 institutionsQ3 2021: 126 institutionsQ4 2021: 133 institutionsQ1 2022: 110 institutionsQ2 2022: 115 institutionsQ3 2022: 127 institutionsQ4 2022: 128 institutionsQ1 2023: 149 institutionsQ2 2023: 133 institutionsQ3 2023: 138 institutionsQ4 2023: 107 institutionsQ1 2024: 98 institutionsQ2 2024: 98 institutionsQ3 2024: 81 institutionsQ4 2024: 98 institutionsQ1 2025: 109 institutionsQ2 2025: 96 institutionsQ3 2025: 103 institutionsQ4 2025: 122 institutionsQ1 2026: 136 institutionsQ2 2026: 148 institutions
Value heldQ4 2025: $252.1M
Q1 2021: $1.14BQ2 2021: $983.4MQ3 2021: $1.02BQ4 2021: $814.9MQ1 2022: $1.02BQ2 2022: $883.3MQ3 2022: $1.00BQ4 2022: $1.04BQ1 2023: $579.3MQ2 2023: $737.2MQ3 2023: $480.0MQ4 2023: $61.4MQ1 2024: $67.5MQ2 2024: $58.1MQ3 2024: $58.5MQ4 2024: $217.0MQ1 2025: $143.8MQ2 2025: $130.4MQ3 2025: $162.8MQ4 2025: $252.1MQ1 2026: $409.4MQ2 2026: $630.0M
Institutions holding ACRS and their total value by quarter
QuarterHoldersValue
Q2 2026148$630.0M
Q1 2026136$409.4M
Q4 2025122$252.1M
Q3 2025103$162.8M
Q2 202596$130.4M
Q1 2025109$143.8M
Q4 202498$217.0M
Q3 202481$58.5M
Q2 202498$58.1M
Q1 202498$67.5M
Q4 2023107$61.4M
Q3 2023138$480.0M
Q2 2023133$737.2M
Q1 2023149$579.3M
Q4 2022128$1.04B
Q3 2022127$1.00B
Q2 2022115$883.3M
Q1 2022110$1.02B
Q4 2021133$814.9M
Q3 2021126$1.02B
Q2 2021128$983.4M
Q1 202197$1.14B

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding Aclaris Therapeutics, Inc.; share changes are against Q3 2025.

Institutions holding ACRS in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Bollard Group LLC804,445$2.42M0.06%−421,031−34.4%Reduced
Susquehanna International Group, LLP916,846$2.76M0.00%+880,609+2,430.1%Added
Aldebaran Capital, LLC954,262$2.87M2.58%−33,436−3.4%Reduced
Deutsche Bank AG987,351$2.97M0.00%+64,038+6.9%Added
Millennium Management LLC1,053,246$3.17M0.00%−501,212−32.2%Reduced
Renaissance Technologies LLC1,125,331$3.39M0.01%−494,400−30.5%Reduced
Citadel Advisors LLC1,205,281$3.63M0.00%−227,396−15.9%Reduced
Connor, Clark & Lunn Investment Management Ltd.1,434,164$4.32M0.01%+366,508+34.3%Added
State Street Corp1,506,403$4.53M0.00%+393,257+35.3%Added
Palo Alto Investors LP1,566,840$4.72M0.66%00.0%Unchanged
Kotler Kevin1,705,929$5.13M3.79%+1,705,929New
D. E. Shaw & Co., Inc.2,096,651$6.31M0.00%−276,575−11.7%Reduced
Acadian Asset Management LLC2,122,399$6.38M0.01%−204,620−8.8%Reduced
Geode Capital Management, LLC2,392,772$7.20M0.00%+3,241+0.1%Added
Adage Capital Partners GP, L.L.C.3,371,000$10.1M0.02%−1,907,144−36.1%Reduced
Morgan Stanley3,415,390$10.3M0.00%−661,856−16.2%Reduced
Decheng Capital LLC4,041,736$12.2M1.64%00.0%Unchanged
Rock Springs Capital Management LP4,453,741$13.4M0.69%−155,568−3.4%Reduced
Vanguard Group Inc6,502,080$19.6M0.00%−13,378−0.2%Reduced
BlackRock, Inc.6,804,841$20.5M0.00%+1,113,489+19.6%Added
Vivo Capital, LLC8,888,888$26.8M1.73%00.0%Unchanged
BML Capital Management, LLC14,250,000$42.9M37.97%00.0%Unchanged
Stonepine Capital Management, LLC0$00.00%−192,900−100.0%Sold out
Algert Global LLC0$00.00%−65,630−100.0%Sold out
Oxford Asset Management LLP0$00.00%−36,351−100.0%Sold out
Velan Capital Investment Management LP0$00.00%−32,700−100.0%Sold out
Engineers Gate Manager LP0$00.00%−17,844−100.0%Sold out
Clearstead Advisors, LLC0$00.00%−1−100.0%Sold out